CASTLE BIOSCIENCES INCCSTLEarnings & Financial Report
Nasdaq
NextMar 30, 2026
CSTL Q3 2025 Key Financial Metrics
Revenue
$83.0M
Gross Profit
$64.3M
Operating Profit
$-6.8M
Net Profit
$-501.0K
Gross Margin
77.5%
Operating Margin
-8.2%
Net Margin
-0.6%
YoY Growth
-3.2%
EPS
$-0.02
Financial Flow
CASTLE BIOSCIENCES INC Q3 2025 Financial Summary
CASTLE BIOSCIENCES INC reported revenue of $83.0M for Q3 2025, with a net profit of $-501.0K (-0.6% margin). Cost of goods sold was $18.7M, operating expenses totaled $71.1M.
Key Financial Metrics
| Total Revenue | $83.0M |
|---|---|
| Net Profit | $-501.0K |
| Gross Margin | 77.5% |
| Operating Margin | -8.2% |
| Report Period | Q3 2025 |
CASTLE BIOSCIENCES INC Annual Revenue by Year
CASTLE BIOSCIENCES INC annual revenue history includes year-by-year totals (for example, 2024 revenue was $332.1M).
| Year | Annual Revenue |
|---|---|
| 2024 | $332.1M |
| 2023 | $219.8M |
| 2022 | $137.0M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $66.1M | $73.0M | $87.0M | $85.8M | $86.3M | $88.0M | $86.2M | $83.0M |
| YoY Growth | 72.5% | 73.6% | 73.5% | 39.5% | 30.5% | 20.6% | -0.9% | -3.2% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $453.3M | $458.5M | $487.3M | $514.6M | $531.2M | $501.7M | $544.7M | $562.8M |
| Liabilities | $62.1M | $56.0M | $63.4M | $73.5M | $75.4M | $61.4M | $89.4M | $95.7M |
| Equity | $391.3M | $402.5M | $423.9M | $441.1M | $455.8M | $440.3M | $455.4M | $467.0M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $18.6M | $-6.8M | $24.0M | $23.3M | $24.4M | $-6.0M | $20.8M | $22.6M |